Qiming Venture Partners

Leyden Labs is a biotechnology company focused on developing intranasal products aimed at protecting individuals from respiratory viruses. By targeting commonalities among various viral families, Leyden Labs seeks to provide broad-spectrum protection against multiple strains of viruses, including those in the influenza and coronavirus families. Unlike traditional vaccines that typically address specific variants, Leyden Labs' innovative approach allows for simultaneous protection against a range of viruses, thereby empowering individuals to safeguard their health and prevent the transmission of diseases. The company's team comprises experienced biotechnology professionals and new talent, all committed to advancing solutions that alleviate the impact of respiratory infections on global health.

AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligo™ ASO platform, the company aims to enhance targeted delivery technologies to improve treatment outcomes. AusperBio is dedicated to addressing a variety of diseases, including viral infections, genetic disorders, metabolic conditions, and immune diseases, through its small interfering ribonucleic acid (siRNA) drugs. By concentrating on effective treatment strategies and vaccination for chronic hepatitis B, AusperBio seeks to provide patients with improved therapeutic options and protection against this challenging disease.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.

Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through innovative digital technologies and the application of artificial intelligence. Prime Lifescience offers a range of services, including a digital smart health community, a digital intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions framework within the healthcare industry, leveraging extensive data to improve health outcomes.

Wecare Probiotics is a national high-tech enterprise focused on the research and development, production, and application of probiotic strains. The company offers a diverse range of probiotic products, including fermented food strains and beneficial microbial flora, suitable for various industries such as food, healthcare, and medicine. By prioritizing quality and efficiency, Wecare Probiotics aims to deliver effective solutions that meet the needs of its customers.

Tourmaline Bio is a clinical biotechnology company focused on developing transformative medicines aimed at improving the lives of patients suffering from immune diseases. The company is in the late stages of clinical development and is centered on its lead product candidate, TOUR006, a fully human monoclonal antibody designed to selectively target interleukin-6 (IL-6), a significant proinflammatory cytokine implicated in various autoimmune and inflammatory disorders. The IL-6 antibody class has a well-established history, with over two decades of clinical and commercial experience, having successfully treated more than a million patients with diverse autoimmune and inflammatory conditions. Through its innovative research, Tourmaline Bio seeks to address the unmet medical needs of patients affected by life-altering immune diseases.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Complete Omics is a developer focused on multi-omics diagnostics aimed at the early detection of diseases, particularly cancer. The company specializes in personalized diagnosis and treatment, leveraging patented technologies across various omics fields. By offering precision companion diagnostics, Complete Omics enables researchers and pharmaceutical companies to conduct highly sensitive and specific health surveillance tests, facilitating improved patient outcomes through tailored medical interventions.

SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Shanghai Fushoukang Rehabilitative Home Nursing Services specializes in in-home rehabilitation and nursing care for the elderly, as well as individuals who are weak, sick, or disabled. Founded in 2011 and headquartered in Shanghai, the company offers a range of services including home care, community care, nursing care, and bathing assistance. By focusing on the needs of vulnerable populations, Fushoukang aims to enhance the quality of life for its clients through personalized care in the comfort of their own homes.

Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through innovative digital technologies and the application of artificial intelligence. Prime Lifescience offers a range of services, including a digital smart health community, a digital intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions framework within the healthcare industry, leveraging extensive data to improve health outcomes.

Ceptur Therapeutics is focused on developing innovative genetic medicines aimed at addressing diseases that currently lack effective treatments. The company utilizes its proprietary U1 Adaptor technology, which enables long-lasting and non-genotoxic silencing of disease-causing genes, particularly in challenging tissues beyond the liver and central nervous system. This technology addresses the limitations of existing gene silencing methods and holds promise for cancer treatment, allowing healthcare providers to offer new therapeutic options for patients with various types of cancers.

Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.

Structure Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel oral therapeutics for chronic diseases with significant unmet medical needs. Utilizing advanced computational and structure-based technology, the company designs orally available small molecules that aim to overcome the limitations of traditional biologic and peptide drugs. Its lead product candidate, GSBR-1290, is a small molecule agonist targeting the glucagon-like peptide-1 receptor, which is relevant for treating type-2 diabetes and obesity. Additionally, Structure Therapeutics is advancing other oral therapeutics targeting G-protein-coupled receptors for conditions such as pulmonary and cardiovascular diseases, including candidates ANPA-0073 and LTSE-2578. The company combines expertise in drug design and development to create differentiated and effective treatments that can have a profound impact on patient care.

Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Health Game Advice: Resist bad games, refuse pirated games, pay attention to self-protection, beware of being deceived, moderate games to benefit the brain, indulge in game injuries, arrange time properly and enjoy a healthy life.

Structure Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel oral therapeutics for chronic diseases with significant unmet medical needs. Utilizing advanced computational and structure-based technology, the company designs orally available small molecules that aim to overcome the limitations of traditional biologic and peptide drugs. Its lead product candidate, GSBR-1290, is a small molecule agonist targeting the glucagon-like peptide-1 receptor, which is relevant for treating type-2 diabetes and obesity. Additionally, Structure Therapeutics is advancing other oral therapeutics targeting G-protein-coupled receptors for conditions such as pulmonary and cardiovascular diseases, including candidates ANPA-0073 and LTSE-2578. The company combines expertise in drug design and development to create differentiated and effective treatments that can have a profound impact on patient care.

Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Structure Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel oral therapeutics for chronic diseases with significant unmet medical needs. Utilizing advanced computational and structure-based technology, the company designs orally available small molecules that aim to overcome the limitations of traditional biologic and peptide drugs. Its lead product candidate, GSBR-1290, is a small molecule agonist targeting the glucagon-like peptide-1 receptor, which is relevant for treating type-2 diabetes and obesity. Additionally, Structure Therapeutics is advancing other oral therapeutics targeting G-protein-coupled receptors for conditions such as pulmonary and cardiovascular diseases, including candidates ANPA-0073 and LTSE-2578. The company combines expertise in drug design and development to create differentiated and effective treatments that can have a profound impact on patient care.

CardiaLen, Inc. is a medical device company based in Minneapolis, Minnesota, specializing in the development of innovative therapies for atrial fibrillation and other heart arrhythmias. Founded in 2008, the company is focused on creating implantable, low-energy cardioverter devices that offer pain-free cardioversion therapies. These devices monitor the heartbeat and employ a proprietary series of low-energy pulses to restore normal heart rhythm while minimizing discomfort and preventing damage to heart tissue. By addressing significant unmet needs in the treatment of atrial fibrillation, CardiaLen aims to enhance patient outcomes and reduce reliance on high-energy defibrillation shocks.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

Health Game Advice: Resist bad games, refuse pirated games, pay attention to self-protection, beware of being deceived, moderate games to benefit the brain, indulge in game injuries, arrange time properly and enjoy a healthy life.

Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.

QIAGEN Suzhou is an innovative start-up providing precision medicine solutions.

Twine Health, Inc. is a healthcare technology company that specializes in a cloud-based platform aimed at chronic disease management. The platform facilitates collaborative care by integrating tools for shared decision-making, self-tracking, and communication between patients and their healthcare providers. Patients can co-create personalized care plans with their care teams, which may include physicians, nurses, family members, and health coaches. This collaborative approach is designed to enhance patient engagement and self-efficacy, ultimately leading to better health outcomes and reduced healthcare costs. Established in 2012 and based in Cambridge, Massachusetts, Twine Health was developed at the MIT Medical Lab and operates as a subsidiary of Fitbit, Inc. since 2018.

IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.

LIH Investment & Management manages and invests in rehabilitation medical institutions. The Company serves customers in China. LIH Investment & Management has always been devoted to invest, manage and operate high-quality rehabilitation medical service organization, introduce internationalization concept, technology and mode into China, promote the professional medical rehabilitation service and management and continuous innovation.

Junhetang operates a network of traditional Chinese medicine (TCM) clinics, providing a range of healthcare services that include herbal medicine, acupuncture, massage, exercise, and dietary therapies. The company combines TCM culture with the expertise of renowned TCM practitioners to deliver personalized medical services. Additionally, Junhetang integrates modern internet services into its offerings, creating an innovative TCM service network that encompasses education, training, medical care, and health maintenance. Headquartered in Nanjing, the company is actively expanding its presence in several major cities across China, including Shanghai, Shenzhen, Chengdu, and Taiyuan.

LIH Investment & Management manages and invests in rehabilitation medical institutions. The Company serves customers in China. LIH Investment & Management has always been devoted to invest, manage and operate high-quality rehabilitation medical service organization, introduce internationalization concept, technology and mode into China, promote the professional medical rehabilitation service and management and continuous innovation.

JHT TCM Clinics

Junhetang operates a network of traditional Chinese medicine (TCM) clinics, providing a range of healthcare services that include herbal medicine, acupuncture, massage, exercise, and dietary therapies. The company combines TCM culture with the expertise of renowned TCM practitioners to deliver personalized medical services. Additionally, Junhetang integrates modern internet services into its offerings, creating an innovative TCM service network that encompasses education, training, medical care, and health maintenance. Headquartered in Nanjing, the company is actively expanding its presence in several major cities across China, including Shanghai, Shenzhen, Chengdu, and Taiyuan.

MedSci specializes in delivering strategies, solutions, and services to the pharmaceutical, biotech, and medical device sectors, as well as the consumer healthcare industry. The company operates a clinical services platform that offers an online resource for medical research, along with clinical and academic translation services. Additionally, MedSci provides a range of services, including clinical research, medical affairs, marketing, and consulting, aimed at enhancing the quality of healthcare for its clients.

BBI Life Sciences Corporation is a prominent provider of life sciences products and services, headquartered in Shanghai, China. Incorporated in 2013, it develops, manufactures, and sells a diverse range of offerings that support scientific research across various regions, including China, North America, South America, Europe, and Africa. The company operates through five main segments: DNA Synthesis Products, Genetic Engineering Services, Life Science Research Consumables, Protein and Antibody Related Products and Services, and Third Party Detection. Its DNA Synthesis Products include oligonucleotides and gene synthesis used in molecular biology and medical research. The Genetic Engineering Services segment offers DNA sequencing and gene analysis, while the Life Science Research Consumables segment supplies biochemical reagents and laboratory tools. The Protein and Antibody segment features kits and services related to protein detection and analysis, along with customized antibody production. Additionally, BBI Life Sciences provides medical detection and diagnosis services. With a strong client base that includes educational institutions, research institutes, hospitals, and biotech companies, the company has established itself as a leader in the life sciences market in China and beyond.

Mitralign is a privately held company based in a suburb of Boston, Massachusetts, focused on developing a catheter-based technology for the treatment of functional mitral regurgitation. The company has created an innovative system that mimics surgical annuloplasty by delivering surgical implants directly into the mitral annulus via a catheter. This process involves cinching the implants together to decrease the size of the mitral valve annulus and the valve opening. Mitralign's technology aims to provide a less invasive option for managing this life-threatening cardiac condition, enabling healthcare providers to effectively treat symptomatic functional mitral regurgitation through tissue-plication. The company is supported by prominent venture capitalists and has attracted investments from major cardiovascular device firms.

WeDoctor is a prominent medical health technology platform founded in 2010 by Liao Jieyuan and his team. The company aims to enhance access to healthcare by leveraging technology to provide a comprehensive range of services. Its mobile application allows users to connect with hospitals and doctors, schedule appointments, and access medical advice and ratings for healthcare providers. By integrating both online and offline medical services, WeDoctor aspires to serve as a health management organization, facilitating improved healthcare experiences for millions of families. The platform emphasizes a user-friendly approach to healthcare, making essential medical services readily available and efficient.

JHT TCM Clinics

Aeonmed Medical Treatment (至尊租车) is a manufacturer and supplier of operating theatre and ICU devices, and medical treatment system solutions. Since its foundation, Aeonmed has always been guided by the clinical demands, and dedicated to the study of clinical medical equipment and solutions. Now, Aeonmed business covers three major product portfolios, including anesthesia and operation support, emergency and critical care and medical engineering equipment, and five major medical system solutions including laminar flow monitoring, environment and equipment configuration, centralized gas supply, process quality control and information integration. Currently, Aeon has more than 600 authorized and declared patents, among which there are more than 400 patents for invention, maintaining an increase of over 100 patents each year.

AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligo™ ASO platform, the company aims to enhance targeted delivery technologies to improve treatment outcomes. AusperBio is dedicated to addressing a variety of diseases, including viral infections, genetic disorders, metabolic conditions, and immune diseases, through its small interfering ribonucleic acid (siRNA) drugs. By concentrating on effective treatment strategies and vaccination for chronic hepatitis B, AusperBio seeks to provide patients with improved therapeutic options and protection against this challenging disease.